We find an expansion of CMV-related NKG2C+ NK cells in CMV-seropositive CLL patients, which skews the expression of activating and inhibitory receptors leaving a footprint on the global NK cell compartment. This evidence concerns the gene KLRC2 and B-cell chronic lymphocytic leukemia.